IP Library Granted Patent US 9,937,271
Granted Patent B2
US 9,937,271 · App. 15/039,628 · Granted Apr 10, 2018

Prevention of

Inventors: Kazutoshi Sawada (Sodegaura, JP); Takeshi Matsui (Sodegaura, JP); Eiji Takita (Sodegaura, JP); Takeshi Matsumura (Sapporo, JP); Akira Ito (Sapporo, JP); Noriko Tabayashi (Kitahiroshima, JP)
Assignees: IDEMITSU KOSAN CO., LTD.; NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY; HOKUSAN CO., LTD.
A61K48/005A61K38/00A61K39/0258
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,937,271
App. No.
15/039,628
Granted
Apr 10, 2018
Kind
B2
Abstract

The present invention provides an agent for controlling Escherichia coli diarrhea comprising a Shiga toxin as an active ingredient.

Claims (11)

1. A method for controlling Escherichia coli diarrhea. in a pig infected with the Escherichia coli , the method comprising administering a Shiga toxin or a transformant containing the Shiga toxin to the pig in need thereof, wherein the Shiga toxin is a hybrid protein comprising two Shiga toxin B subunit proteins (Stx2eB) tandemly linked via a peptide linker, and wherein the Escherichia coli produces heat-labile toxin (LT) and/or heat-stable toxin (ST) but does not produce Stx2e toxin.

2. The method according to claim 1 , wherein the Shiga toxin is administered as a transformant which is transformed with a recombinant vector containing a DNA construct comprising a DNA coding for the hybrid protein, and expresses the hybrid protein.

3. The method according to claim 1 , wherein the hybrid protein is administered as a transformant which is transformed with a recombinant vector containing a DNA construct comprising a DNA coding for the hybrid protein, and expresses the hybrid protein.

4. The method according to claim 2 , wherein the transformant is a vegetative-propagation plant.

5. The method according to claim 4 , wherein the vegetative-propagation plant s strawberry.

6. The method according to claim 1 , wherein the pig is a pig in the lactation period or of up to 120-day old, or a mother pig.

7. A method of improving fattening of a pig infected with a toxin-producing Escherichia coli , comprising administering a Shiga toxin as an active ingredient to the pig in need thereof, wherein said Shiga toxin protein is a hybrid protein comprising two Shiga toxin B subunit proteins (Stx2eB) tandemly linked via a peptide linker, and wherein said Escherichia coli produces heat-labile toxin (LT) and/or heat-stable toxin (ST) but does not produce Stx2e toxin.

8. The method according to claim 7 , wherein the Shiga toxin is administered as a transformant which is transformed with a recombinant vector containing a DNA construct comprising a DNA coding for the hybrid protein, and expresses the hybrid protein.

9. The method according to claim 7 , wherein the Shiga toxin is administered as a transformant which is transformed with a recombinant vector containing a DNA construct comprising a DNA coding for a hybrid protein comprising the hybrid protein, and expresses the hybrid protein.

10. The method according to claim 8 , wherein the transformant is a vegetative-propagation plant.

11. The method according to claim 10 , wherein the vegetative-propagation plant is strawberry.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2016
From: SAWADA, KAZUTOSHI; MATSUI, TAKESHI; TAKITA, EIJI; MATSUMURA, TAKESHI; ITO, AKIRA; TABAYASHI, NORIKO
To: IDEMITSU KOSAN CO., LTD.; NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY; HOKUSAN CO. LTD
Reel/Frame 039900/0577 →
Priority Claims (1)
JP 2013-244096 · Nov 26, 2013 · national
Continuity (1)
Related Publication 20170173179A1 · Jun 22, 2017